Despite the many economic and market risks out there, these growth stocks are well positioned to skyrocket as we head into 2026.
Blackberry
Blackberry provides governments and enterprises with intelligent software and services to power the many corners of the world. From mission-critical communications to the software-driven car: Blackberry has its hands in transformative, lucrative markets.
The QNX division is the highest growth segment of the company with the most opportunity. Blackberry’s systems connect cars and introduce machine-to-machine connectivity to medical devices, industrial applications and robotics.
In the last quarter, Blackberry’s results exceeded expectations. QNX segment revenue grew 15%, with an EBITDA (earnings before interest, taxes, depreciation and amortization) margin of 32%. This is a far cry from the days when the company was operating at a loss, and it’s a sign that things are looking up.
Blackberry will report third-quarter 2026 results on Thursday. The company expects revenue to be between $132 million and $140 million, with adjusted EBITDA of $20 to $28 million. The company is targeting earnings per share (EPS) of $0.02 to $0.04. This compares to $0.01 in the same quarter last year.
Finally, analyst expectations favor Blackberry reporting earnings per share of $0.04. Blackberry stock has been essentially flat over the past year. But if the company continues to beat earnings expectations, the stock should do quite well. Revenue trends and backlog are also important variables to monitor; the company’s backlog was ahead of plan last quarter. Blackberry shares trade at 42 times this year’s expected earnings.
Well, health technologies
As the largest Canadian digital health company, Well Health Technologies has experienced rapid growth in recent years. This comes at a time when the healthcare market is yearning for change: better outcomes, better efficiency and a better connection to the benefits of the digital world.
Well Health has made these improvements to the healthcare system. And judging by the rapid turnout, we can see that they are much needed and much appreciated. In Well Health’s third quarter, revenue rose 56% to $365 million and adjusted earnings per share came in at $0.06, compared to a loss of $0.33 in the same period in 2024. And free cash flow came in at $31.2 million.
So we can see that Well Health’s profitability is increasing. Looking ahead, the company will continue to improve its operations by focusing its activities. The American activities will be spun off and the emphasis will be on the Canadian activities. This is the company with the highest return on invested capital for Well Health.
However, Well Health shares have not shown as much enthusiasm as the growth numbers and plans suggest. In my view, investors are likely to feel better about the stock now that Well Health is divesting its non-core US operations.
The bottom line
The two growth stocks discussed in this article both benefit from strong long-term trends. Both are well positioned in their respective sectors, and both are likely to do well in the long term.
#growth #stocks #expected #rise